Novo Nordisk
NVO
#40
Rank
$240.79 B
Marketcap
๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Country
$104.65
Share price
1.18%
Change (1 day)
47.85%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2021 (TTM): $8.54 B

According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are $8.54 B. In 2020 the company made an earning of $8.34 B an increase over its 2019 earnings that were of $7.60 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Novo Nordisk from 2001 to 2021

Year Earnings Change
2021 (TTM)$8.54 B2.35%
2020$8.34 B9.73%
2019$7.60 B2.08%
2018$7.45 B-1.24%
2017$7.54 B1.27%
2016$7.45 B9.13%
2015$6.82 B28.25%
2014$5.32 B4.73%
2013$5.08 B9.8%
2012$4.62 B29.72%
2011$3.56 B12.49%
2010$3.17 B33.37%
2009$2.37 B22.86%
2008$1.93 B38.51%
2007$1.39 B-1.78%
2006$1.42 B12.94%
2005$1.26 B18.1%
2004$1.06 B7.89%
2003$0.98 B20.88%
2002$0.81 B-14.39%
2001$0.95 B